This protocol is judged by an institutional assessment board, an independent team that assessments any clinical trials involving humans. If a study entails a Plan I drug, after the board approves the protocol as moral, the researchers must make an application for an investigational new drug (IND) selection with the FDA.Drugs may additionally compri